ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 241

Histological and Clinical Correlates of Ultrasound Measures of Joint Inflammation: Analysis of RA Tissue Obtained By Ultrasound Guided Biopsy in Phase 1 of the Accelerating Medicines Partnership RA Network

Andrew Filer1, Arthur M. Mandelin II2, Edward F. DiCarlo3, Brendan Boyce4, Darren Tabechian5, Ralf G. Thiele6, Stephan Kelly7, Ellen M. Gravallese8, Diane Horowitz9, Kevin Wei10, Deepak Rao11, Vivian P. Bykerk12 and Jennifer H. Anolik13, 1Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 2Rheumatology, Northwestern University, Chicago, IL, 3Laboratory Medicine, Hospital for Special Surgery, New York, NY, 4University of Rochester Medical Center, Rochester, NY, 5Medicine, Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 6Medicine, University of Rochester Medical Center, Rochester, NY, 7Queen Mary University of London, London, United Kingdom, 8Lazare Research Bldg, University of Massachusetts Medical School, Worcester, MA, 9Division of Rheumatology, North Shore - Long Island Jewish Health System, Woodbury, NY, 10Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Spring, IN, 122-005, Mt Sinai Hospital, Toronto, ON, Canada, 13Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Disease Activity, Rheumatoid arthritis (RA), synovitis and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

The AMP-RA network applies cutting edge technologies to the study of tissue obtained by ultrasound guided synovial biopsy from patients with rheumatoid arthritis (RA). Ultrasound provides objective joint level measures of synovial inflammation, including hypertrophy (greyscale ultrasound, GSUS) and hyperaemia (Power Doppler ultrasound, PDUS). Furthermore, ultrasound joint count assessments enable higher sensitivity for measurement of systemic disease activity compared to clinical joint assessments alone. We examined the relationship between joint level ultrasound variables and synovial histology in Phase I patients with active RA. we also validated ultrasound measures against conventional measures of disease activity.

Methods:

During Phase I of AMP-RA we recruited patients fulfilling clinician RA diagnosis, 1987 or 2010 ACR/EULAR RA criteria with at least one joint amenable to biopsy. Patients were required to have a CDAI≥10; patients receiving i.a. steroids in the previous 4 weeks, i.m. in the last 8 weeks or oral steroids >10mg were excluded. 12 joint extended ultrasound assessments of 10 MCPs and 2 wrist joints using four point semiquantitative GSUS and PDUS scales were performed alongside collection of standard RA disease activity measures including DAS28CRP domains. 12 joint ultrasound indices were calculated by summing 0-3 grades for all joints. GSUS and PDUS measures were also assessed in the biopsied joint prior to the procedure. Retrieved tissue was fixed, stained and paraffin embedded prior to sectioning and staining by H&E. Tissues were assessed for quality: Where 50% or more tissue fragments out of a minimum of 4 contained lining layer histology, tissues were Krenn scored for lining layer and inflammatory infiltrate, and qualitative assessment of tissue pathotype by three histologists. In parallel, tissues were enzymatically disaggregated and cell yield determined using trypan dye exclusion.

Results:

In 15 tissue samples meeting QC taken from wrist (5), knee (9) and MCP (1) joints, Greyscale ultrasound (GSUS) grade correlated with the Krenn index of cellular inflammation (p<0.01, r=0.65) and the Krenn lining layer score (p<0.05, r=0.52). Power Doppler Ultrasound (PDUS) grade failed to correlate with either histological measure (p=0.34, p=0.48 respectively). Tissues with higher USGS, but not USPD scores, were more likely to show a lymphocyte predominant histological pathotype than other patterns (p<0.05). There was no consistent relationship between GSUS or PDUS measures of synovitis and cell yield at tissue disaggregation. GSUS extended joint indices correlated with DAS28CRP, 28 swollen joint and tender joint counts (p<0.05, r=0.70; p<0.01, r=0.78; p<0.05, r=0.65), while PDUS extended joint indices correlated with DAS28CRP and 28 swollen joint counts (p<0.05, r=0.66; p<0.05 r=0.76).

Conclusion:

Ultrasound measures of synovial hypertrophy correlate with the complexity of joint infiltrates and lining layer thickness. There was an association between synovial hypertrophy and a lymphocyte predominant pathotype. Extended joint indices demonstrate validity when compared to existing clinical domains.


Disclosure: A. Filer, None; A. M. Mandelin II, None; E. F. DiCarlo, None; B. Boyce, None; D. Tabechian, None; R. G. Thiele, Amgen, 8,AbbVie, 8,BioClinica, 5,Fujifilm SonoSite, 9; S. Kelly, None; E. M. Gravallese, Abbott Immunology Pharmaceuticals, 2,Lilly, Inc, 2,New England Journal of Medicine, 3,Up to Date, 7,Lilly Inc., 5,Sanofi/Genzyme, 5; D. Horowitz, None; K. Wei, None; D. Rao, None; V. P. Bykerk, None; J. H. Anolik, None.

To cite this abstract in AMA style:

Filer A, Mandelin AM II, DiCarlo EF, Boyce B, Tabechian D, Thiele RG, Kelly S, Gravallese EM, Horowitz D, Wei K, Rao D, Bykerk VP, Anolik JH. Histological and Clinical Correlates of Ultrasound Measures of Joint Inflammation: Analysis of RA Tissue Obtained By Ultrasound Guided Biopsy in Phase 1 of the Accelerating Medicines Partnership RA Network [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/histological-and-clinical-correlates-of-ultrasound-measures-of-joint-inflammation-analysis-of-ra-tissue-obtained-by-ultrasound-guided-biopsy-in-phase-1-of-the-accelerating-medicines-partnership-ra-ne/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histological-and-clinical-correlates-of-ultrasound-measures-of-joint-inflammation-analysis-of-ra-tissue-obtained-by-ultrasound-guided-biopsy-in-phase-1-of-the-accelerating-medicines-partnership-ra-ne/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology